Levodopa

New drugs for treatment of Parkinson’s disease 1:47
New drugs for treatment of Parkinson’s disease
Fabrizio Stocchi • 18 Mar 2022
Latest developments in symptomatic treatment of Parkinson’s disease 1:47
Latest developments in symptomatic treatment of Parkinson’s disease
Fabrizio Stocchi • 18 Mar 2022
Predictors of augmentation in RLS 1:50
Predictors of augmentation in RLS
Evi Holzknecht • 14 Mar 2022
The impact of LCIG on dyskinesia duration & severity in PD 4:19
The impact of LCIG on dyskinesia duration & severity in PD
Alfonso Fasano • 22 Sep 2021
Upcoming treatments for Parkinson’s disease 1:10
Upcoming treatments for Parkinson’s disease
Zvezdan Pirtosek • 27 Sep 2021
Parkinson’s disease: what’s to come in 2022? 3:20
Parkinson’s disease: what’s to come in 2022?
Angelo Antonini • 24 Sep 2021
The current treatment landscape for PD 1:21
The current treatment landscape for PD
Caroline Tanner • 14 Sep 2021
The use of amantadine in Parkinson’s disease 2:13
The use of amantadine in Parkinson’s disease
Caroline Tanner • 14 Sep 2021
The efficacy of amantadine as an early add-on for motor complications 3:15
The efficacy of amantadine as an early add-on for motor complications
Caroline Tanner • 14 Sep 2021
Continuous dopaminergic stimulation to prevent motor complications in Parkinson’s disease 3:42
Continuous dopaminergic stimulation to prevent motor complications in Parkinson’s disease
Angelo Antonini • 24 Sep 2021
Should device-aided treatment be given earlier in Parkinson’s disease? 14:59
Should device-aided treatment be given earlier in Parkinson’s disease?
Zvezdan Pirtosek • 27 Sep 2021
LECIG for motor fluctuations in Parkinson’s disease 3:28
LECIG for motor fluctuations in Parkinson’s disease
Dag Nyholm • 24 Jun 2021
Carbidopa/levodopa enteral suspension for PD 1:38
Carbidopa/levodopa enteral suspension for PD
Gian Pal • 30 Apr 2021
Improving levodopa delivery in PD 4:28
Improving levodopa delivery in PD
Daniele Urso • 19 Feb 2021
Dopamine agonist phobia in PD 4:51
Dopamine agonist phobia in PD
Lucia Batzu • 19 Mar 2021
Treatment options for dystonia: anticholinergics, levodopa, botulinum toxin and DBS 3:57
Treatment options for dystonia: anticholinergics, levodopa, botulinum toxin and DBS
Susanne Schneider • 17 Sep 2020
The content of VJNeurology is intended for healthcare professionals